~~<i id='1D18013FE2'><strike id='1D18013FE2'><tt id='1D18013FE2'><pre id='1D18013FE2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

comprehensive

author：entertainment 2025-09-30 00:39:04 - browse：68512

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LONDON — Novo Nordisk said Monday it would acquire the German firm Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional drug candidates for its pipeline of cardiometabolic medicines.

Cardior focuses on targeting RNA to address the root causes of heart disease. Its lead candidate, known CDR132L, is in Phase 2 development as a treatment for health failure.

The companies did not disclose how much Novo was paying upfront for Cardior and how much would be based on future milestones being achieved. The deal is expected to close in the second quarter.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： What health policies could hitch a ride on a spending bill?

leisure time

entertainment

leisure time

focus

Wikipedia

entertainment

What’saradiopharmaceutical?WhatdoesitmeantobeZepbound?Andwho’stoblameforabiotechblow-up?Wecoverallth

WSS

Surgeons perform first xenotransplant using CRISPR'd pig kidney

What is STAT's opinion section for?

Bring on the sabbaticals for nurses

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

With Wegovy coverage, Medicare patients may face high costs

Cancer, immunology, HIV research ensnared in fetal tissue politics

leisure time

comprehensive

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medicare’s new pay boost for primary care is angering specialists

Medical leaders decry Supreme Court decision on affirmative action

Erich Jarvis studies song birds to learn about human stuttering

23andMe had bad news about my health. I wish a person had delivered it

What health policies could hitch a ride on a spending bill?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A letter from the executive editor: STAT UnitedHealth investigation

Wildfire smoke exposes gaps in outdoor worker protections

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

entertainment

After decades in use, heart stents finally beat placebo

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Study suggests Covid rebound is far more common with Paxlovid than without

Medical devices makers are asking for forgiveness, not permission

Yancopoulos of Regeneron works to expand Dupixent success

What health policies could hitch a ride on a spending bill?

leisure time

focus

Wikipedia

entertainment